Jump to content

Group 1 CD1-restricted T cells

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 18:51, 30 January 2022 (Alter: template type, pmc, doi. Add: s2cid, pmc, pmid, doi-access, page, doi, authors 1-1. Removed proxy/dead URL that duplicated identifier. Removed parameters. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | Suggested by Headbomb | #UCB_toolbar). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Group 1 CD1-restricted T cells are a heterogeneous group of unconventional T cells defined by their ability to recognize antigens bound on group 1 CD1 molecules (CD1a, CD1b and CD1c) with their TCR, whereas affinity to CD1d (the only group 2 CD1 molecule) defines the more well studied natural killer T (NKT) cells. These cells recognize lipid antigens in contrast to the conventional peptide antigens presented on MHC class 1 and 2 proteins. Most identified T-cells that bind group 1 CD1 proteins posses the αβ TCR but γδ T cells have also been discovered. Both foreign and endogenous lipid antigens activate these cells.[1][2]

The TCR usually recognizes the hydrophilic part of the antigen which protrudes outwards from the CD1 protein after the lipid chains are bound in a groove. Small hydrophobic antigens lacking a polar part have also been shown to activate CD1a-restricted T cells, indicating that in this case the TCR may bind CD1 directly following displacement of nonimmunogenic ligands.[3]

Group 1 CD1 proteins

CD1 is a family of surface glycoproteins expressed on antigen presenting cells (chiefly dendritic cells) where they can be used as cell markers. A subset of B cells expresses CD1c. These proteins are related to MHC class 1 molecules but have a high affinity for the lipidic moieties of antigens. Humans express 5 members of this family (CD1a-e) from a region on chromosome 1 classified as group 1 (CD1a-c), group 2 (CD1d) and group 3 (CD1e, which does not function in antigen presentation). Mice express 2 orthologues of CD1d (CD1d1 and CD1d2) but lack any counterpart for group 1 proteins, which has complicated the research of in vivo fuction.[4]

CD1 proteins are structurally similar to MHC class 1 proteins, containing 3 domains and non-covalently bound β2 microglobulin. They lack the genetic diversity typical of MHC genes and have a very limited number of polymorphisms, most of which produce silent mutations. Their variability reflects that of the lipid repertoire of organisms, which changes rarely compared to mutations in proteins.[4]

On their way through the endoplasmatic reticulum and golgi network they aquire nonimmunogenic lipid spacers. These spacers were identified to be diacylglycerides or deoxyceramides and their variety may explain the broad range of lipid chain lengths that group 1 CD1 proteins can accomodate, as the spacers have been observed to slide into different positions for different antigens.[5] After CD1 proteins reach the surface of the cell, they are internalized and the members show different patterns of localization with CD1b trafficking through late endosomes and lysosomes and CD1a localizing mostly in early endosomes. CD1c broadly localizes in a combination of the above mentioned compartments. CD1 proteins exchange their spacers for immunogenic ligands in endosomes and lysosomes with the help of several lipid transfer proteins (including CD1e).[4]

Function

In vivo studies have been hindered by the lack of orthologous proteins in mice. Humanized or transgenic mice are used to overcome this discrepancy and some studies use different animal species. Their function in Mycobacterium tuberculosis infection has been the main focus in past research.[6]

Group 1 CD1-restricted T cells are more similar to conventional T cells because their response takes up to several weeks and they exhibit an accelerated response after prior immunization. This differs from their group 2 counterparts (Natural killer T cells) which react swiftly but undergo anergy following reexposure.[7]

Mycobacterium tuberculosis infection

Many lipid antigens of Mycobacterium tuberculosis have been indentified, including: mycolic acid, glucose and glycerol monomycolates, lipoarabinomannan, phosphatidylinositol mannoside, diacylsulfoglycolipid, mannosyl-β-1-phosphomycoketide and didehydroxymycobactin. Most of these antigens are bound to CD1b.[5]

Group 1 CD1-restricted T cells are activated after Mycobacterium infection and produce IFN-γ and TNF-α (Th1 type response). These cells can be double negative (CD4-CD8-), CD4+ or CD8+ and posses strong cytotoxic capabilities. Studies using CD1b tetramers presenting the mycobacterial product glucose monomycolate identified a CD4+ TCRαβ+ T cell population termed 'GEM (Germline-encoded, mycolyl-reactive)' for their conserved TCR repertoire (specifically TRAV1-2+TRAJ9+) which differs from the otherwise variable TCR composition of isolated subsets. These cells are rare in individuals that have not encountered Mycobacterium tuberculosis.[1]

CD1 expression is downregulated in antigen presenting cells infected with live Mycobacteria, perhaps as a means of immune evasion. This downregulation can be also found in some leukemia cells.[4]

Autoreactivity

Group 1 CD1-restricted T cells can be activated by endogenous lipids, including gangliosides (GM1,GD1a, GD1b, GT1b, and GQ1b), sulfatides, sphingomyelin, phophatidylglycerol, lysophospholipids, squalene, wax esters, and triacylglycerides.[5]

Methyl-lysophosphatidic acids (mLPAs) are rare in healthy monocytes and B cells but are abundant in leukemic cells. CD1c self-reactive T cells were found to kill acute leukemia cells expressing CD1c binding these lipids.[8]

CD1a self-reactive T cells were found in the blood of healthy individuals.[9] These cells express skin-homing receptors and produce interleukin 22 after binding CD1a on Langerhans cells. CD1a binds many endogenous lipids found in skin-oil and is able to activate T-cells even with ligands that lack a hydrophilic part, e.g. squalene.[2][3]

CD8+ TCR αβ+ CD1b T cells have been found in the central nervous system of patients with multiple sclerosis. They recognized glycolipids and secreted IFN-γ and TNF-α.[10]

References

  1. ^ a b Kabelitz, Dieter (2017-05-24). "Faculty Opinions recommendation of The burgeoning family of unconventional T cells". Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. doi:10.3410/f.725857548.793532503. Retrieved 2022-01-30.
  2. ^ a b Siddiqui, Sarah; Visvabharathy, Lavanya; Wang, Chyung-Ru (2015). "Role of Group 1 CD1-Restricted T Cells in Infectious Disease". Frontiers in Immunology. 6: 337. doi:10.3389/fimmu.2015.00337. ISSN 1664-3224. PMC 4484338. PMID 26175733.
  3. ^ a b de Jong, Annemieke; Cheng, Tan-Yun; Huang, Shouxiong; Gras, Stephanie; Birkinshaw, Richard W; Kasmar, Anne G; Van Rhijn, Ildiko; Peña-Cruz, Victor; Ruan, Daniel T; Altman, John D; Rossjohn, Jamie (2013-12-22). "CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens". Nature Immunology. 15 (2): 177–185. doi:10.1038/ni.2790. ISSN 1529-2908. PMC 3932764. PMID 24362891.
  4. ^ a b c d Brigl, Manfred; Brenner, Michael B. (2004-04-01). "CD1: Antigen Presentation and T Cell Function". Annual Review of Immunology. 22 (1): 817–890. doi:10.1146/annurev.immunol.22.012703.104608. ISSN 0732-0582. PMID 15032598.
  5. ^ a b c Mori, Lucia; Lepore, Marco; De Libero, Gennaro (2016-05-20). "The Immunology of CD1- and MR1-Restricted T Cells". Annual Review of Immunology. 34 (1): 479–510. doi:10.1146/annurev-immunol-032414-112008. ISSN 0732-0582. PMID 26927205.
  6. ^ Siddiqui, Sarah; Visvabharathy, Lavanya; Wang, Chyung-Ru (2015). "Role of Group 1 CD1-Restricted T Cells in Infectious Disease". Frontiers in Immunology. 6: 337. doi:10.3389/fimmu.2015.00337. ISSN 1664-3224. PMC 4484338. PMID 26175733.
  7. ^ Felio, Kyrie; Nguyen, Hanh; Dascher, Christopher C.; Choi, Hak-Jong; Li, Sha; Zimmer, Michael I.; Colmone, Angela; Moody, D. Branch; Brenner, Michael B.; Wang, Chyung-Ru (2009-10-05). "CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice". Journal of Experimental Medicine. 206 (11): 2497–2509. doi:10.1084/jem.20090898. ISSN 0022-1007. PMC 2768849. PMID 19808251.
  8. ^ Lepore, Marco; de Lalla, Claudia; Gundimeda, S. Ramanjaneyulu; Gsellinger, Heiko; Consonni, Michela; Garavaglia, Claudio; Sansano, Sebastiano; Piccolo, Francesco; Scelfo, Andrea; Häussinger, Daniel; Montagna, Daniela (2014-06-16). "A novel self-lipid antigen targets human T cells against CD1c+ leukemias". Journal of Experimental Medicine. 211 (7): 1363–1377. doi:10.1084/jem.20140410. ISSN 1540-9538. S2CID 337069.
  9. ^ de Jong, Annemieke; Peña-Cruz, Victor; Cheng, Tan-Yun; Clark, Rachael A; Van Rhijn, Ildiko; Moody, D Branch (December 2010). "CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire". Nature Immunology. 11 (12): 1102–1109. doi:10.1038/ni.1956. ISSN 1529-2908. PMC 3131223. PMID 21037579.
  10. ^ Shamshiev, Abdijapar; Donda, Alena; Carena, Ilaria; Mori, Lucia; Kappos, Ludwig; De Libero, Gennaro (May 1999). <1667::aid-immu1667>3.0.co;2-u "Self glycolipids as T-cell autoantigens". European Journal of Immunology. 29 (5): 1667–1675. doi:10.1002/(sici)1521-4141(199905)29:05<1667::aid-immu1667>3.0.co;2-u. ISSN 0014-2980. PMID 10359121.